Byetta Linked to Cancer In Rat Studies
This bad news for consumers as well as bad news for Eli Lilly and Amlyn Pharmaceuticals. Recent studies have shown an increase of instances of thyroid cancer in rats treated with Byetta. It appears the drug may be following in the footsteps Novo Nordisk’s competing Victoza, which hold a similar warning. Granted, the Byetta dose
Read MoreFDA Considers 5 Year Limit on Fosamax Use
This is a long time coming. It is about time that the FDA is finally coming around to the notion that long-term use of bisphosphonates like Fosamax is just a bad idea. The simple fact is that the longer a person uses Fosamax, the greater the likelihood that he/she will suffer from a severe, disabling
Read MoreThe Michael Brady Lynch Firm Salutes the Fallen Heroes of 9/11
Today marks the 10-year anniversary of the 9/11 terrorist attacks. I think almost everyone can remember exactly what they were doing at the moment they heard that America was at war. Having been born and raised a youngster in New York City, the Twin Towers were always a magical sight to behold as both a
Read MoreLexapro Launched in Japan Despite Birth Defect Risks
This is Michael Brady Lynch, lead trial attorney at The Michael Brady Lynch Firm. I always find it baffling that even in the face of overwhelming evidence that a drug causes severe side effects that far outweigh the benefits of treatment, drug companies can push through an approval process with the pressure and influence of
Read More